Both well-established and small, clinical-stage pharma companies are investing heavily to be able to someday compete with ...

Novartis' blockbuster immunology drug Cosentyx has disappointed in a phase 3 trial involving patients with giant cell ...

After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

New PICCOLO trial analyses showed that mirvetuximab soravtansine achieved 52% response rates and 27-month overall survival in ...

The findings from this landmark publication, featured on the cover of Science, have accelerated our ability to develop first-in-class medicines for historically intractable targets, validating the ...

Morgan Stanley initiated coverage on three AI-integrated biotechnology firms, Absci, Schrodinger (NASDAQ:SDGR), and Recursion Pharmaceuticals, flagging divergent business models and upcoming catalysts ...

Regeneron Pharmaceuticals, Inc. REGN obtained FDA approval for linvoseltamab-gcpt for the treatment of relapsed or refractory ...

The African Pharmaceutical Market is projected to grow at an impressive CAGR of 6-8% by 2029, driven by a booming population, ...

The Business Research Company The Business Research Company's Estrogen Receptor Modulators Global Market Report 2025 – Market Size, Trends, ...

That’s where anti-inflammatory therapeutics come into play, offering hope for millions of people living with chronic inflammation. The global anti-inflammatory therapeutics market size was $98,026 ...

The company joins a wave of global pharma companies reshoring operations to strengthen the US supply chain and meet patient ...